like us on facebook connect with us on linkedin March 20, 2024


To learn more about Bristol Myers Squibb's Reblozyl, click here

Section Header Section Header Section Header

MSHO Featured Corporate Sponsor Assistance Programs

• AVEO ACE
• Kyowa Kirin Cares
• Takeda Oncology's Here2Assist 

Details >
Section Header

WPS Oncology Related LCD Updates

Stay current on new, retired, and revised policies/articles

Details >

WPS Recent Oncology Related News

• Claim Entry & Number of Units
• MBI Number & Prior Authorization
• Change Healthcare Security Incident
• Updated Medicare Hot Links
• And More

Details >

WPS Educational Offerings

New training opportunities available

Details >
Section Header

CMS-Medicare

Recent Oncology Related Articles

• CMS Update to Conversion Factor
• Change Healthcare Security Incident
• MLN Matters
• And More

Details >

QPP

Relevant Small Practice Resources

Details >

MIPS

CMS Announces Reopening of 2023 MIPS EUC Application

• Extended MIPS Data Submission Deadline
• What If We’ve Already Submitted Some Data?
• How Do I Apply?
• And More

Details >

Recent RAC Monitor Article

This edition includes articles on

• MAC Misinterprets NCD, Denial Ensues
• Connection Between Observation Rate & CMI
• Medical Coding for Monoclonal Antibody Immunization
• Biopsy Coding & Breaking Through Complexities

Details >
Section Header

BCBSM/BCN

Recent Oncology Related News

• Procrit in the Office

Details >

BCBSM/BCN

Publications

• The Record
• BCN Provider News

Details >
Section Header

Current Payer Issue Tracking Page

Last Reviewed/Updated 3-18-24

New! Procrit or Epoetin Class Drugs Maintenance
New! EPO injections for MDS diagnosis
New! Multiple J Codes: Same Drug Class, Different Manufacturer
• And more

Details >

Health Alliance Plan

• Update Provider Information in NPPES
• Claims Processing for Pay Date Feb. 27
• Availity As Temporary Clearinghouse
• And More

Details >

Humana

• Humana Update Re: Cyber Security Incident

Details >

Medicaid

• Manage Prescription Drug Costs
• MSA Bulletin Updates
• Biller "B" Aware Notices

Details >

Priority Health Update

• Change Healthcare Outage Update
• POS 02 Virtual Care Services Reimbursed at Facility-Based Rate
• Updated 2024 PIP Manual
• Ensure Your Primary Specialty is Entered in CHAMPS
• And More

Details >

United Healthcare

• Provider Portal Access Changes
• Reimbursement Policy Updates
• Special Medical Injectable Drug Program Updates
• Pharmacy & Clinical Updates
• And More

Details >
Section Header

Recent Oncology Related FDA Approvals and Expanded Indications

• Takeda Oncology Iclusig
• Bristol Myers Squibb Breyanzi
• BeiGene Brukinsa
• Bristol Myers Squibb Opdivo
Details >

Section Header Section Header

ASK MSHO

March 2024 Frequently Asked Questions

• Coding a Secondary Neoplasm as Primary
• Carcinomas in Situ Vs Benign Neoplasms
• Uncertain Vs. Unspecified Neoplasms

Details >